GILEAD SCIENCES, INC. - 30 Jun 2025 SCHEDULE 13G/A Report for Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

Filing Manager: GILEAD SCIENCES, INC.
Reporting Manager: GILEAD SCIENCES, INC.
Security: Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: XLO
Shares outstanding: 53,336,402 shares
Disclosed Ownership: 10,613,944 shares
Ownership: 20%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 16:42:16 UTC
Date of event: 30 Jun 2025
Previous filing: 19 Dec 2024
Next filing: 12 Feb 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GILEAD SCIENCES, INC.	20%	10,613,944	10,613,944	0	/s/ Andrew D. Dickinson	Executive Vice President and Chief Financial Officer